What is Alzamend Neuro Inc (ALZN) stock price today?

Alzamend Neuro Inc (ALZN) currently trades at $1.14 per share. The stock has a market capitalization of $4.03M and a P/E ratio of —x.

Is ALZN stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Alzamend Neuro Inc has a Smart Value Score of 23/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -16.35.

Is Alzamend Neuro Inc financially healthy?

Alzamend Neuro Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -16.35 places it in the distress.

ALZN

Alzamend Neuro Inc

NASDAQ: ALZN · HEALTHCARE · BIOTECHNOLOGY

$1.14

+7.55% today

Updated 2026-04-30

Market cap

$4.03M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.67

Dividend yield

—

52W range

$1 – $6

Volume

0.1M

Market cap

$4.03M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.67

Dividend yield

—

52W range

$1 – $6

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.3

Quality

C+

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-16.4

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$25.00

+2092.98%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -16.35 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-1.74M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-12.36M	$-14.88M	$-9.95M	$-4.51M	$-2.20M
EPS	—	—	—	—	$-3.67
Free cash flow	$-6.72M	$-8.92M	$-8.42M	$-6.87M	$-1.74M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ALZN	$4.03M	23	4.3	3.0	5.0	5.3	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Alzamend Neuro Inc trades at $1.14. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -16.35, it sits in the distress.

Frequently asked questions

What is Alzamend Neuro Inc's stock price?

Alzamend Neuro Inc (ALZN) trades at $1.14.

Is Alzamend Neuro Inc overvalued?

Smart Value Score 23/100 (Grade F, Strong Sell).

What is the price target of Alzamend Neuro Inc (ALZN)?

The analyst target price is $25.00, representing +2093.0% upside from the current price of $1.14.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-16.35 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-250.00%

Beta-0.05

50D MA$1.54

200D MA$2.13

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ALZN vs LLY →ALZN vs JNJ →ALZN vs ABBV →Stock screener →